KEBILIDI 560000000000 {GC}/mL
eladocagene exuparvovec-tneq · SUSPENSION · PTC Therapeutics, Inc.
Kebilidi is a prescription medicine injected directly into the brain to treat a rare genetic disorder affecting the nervous system. It contains a modified virus designed to deliver a functional gene to brain cells.
Key Facts
- Brand Name
- KEBILIDI
- Generic Name
- eladocagene exuparvovec-tneq
- NDC Code (Product)
52856-601- Manufacturer
- PTC Therapeutics, Inc.
- Strength
- 560000000000 {GC}/mL
- Dosage Form
- SUSPENSION
- Route
- INTRACEREBRAL
- Marketing Status
- Application #
- BLA125722
- Marketing Start
- 11/13/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is KEBILIDI used for?
Kebilidi is a prescription medicine injected directly into the brain to treat a rare genetic disorder affecting the nervous system. It contains a modified virus designed to deliver a functional gene to brain cells.
Is KEBILIDI a controlled substance?
KEBILIDI is not classified as a controlled substance by the DEA.
What is the generic name for KEBILIDI?
The generic name for KEBILIDI is eladocagene exuparvovec-tneq. There are no other listed brand versions of eladocagene exuparvovec-tneq.
What is the NDC code for KEBILIDI 560000000000 {GC}/mL?
The NDC (National Drug Code) for KEBILIDI 560000000000 {GC}/mL is 52856-601, listed by PTC Therapeutics, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)